Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Redwood Pharma to present at Aktiespararnas Stora Aktiedagen Digitalt in Stockholm on November 30, 2020

On November 30, CEO Martin Vidaeus from Redwood Pharma will present at Aktiespararnas Stora Aktiedagen Digitalt (www.aktiespararna.se/aktiviteter/evenemang) in Stockholm. The presentation will be in English. The program and registration for the event can be found on the event’s website, where a link to the live streamed broadcast of the presentation will also be available on November 30. The company will present: · An update of the company’s operations and milestones · An update of RP101 and its development · An introduction to the new RP501 dry eye program · Plans for the

Neles Corporation comments on Valmet Corporation's merger proposal

Neles Corporation Stock Exchange Release 12 October 2020 at 9:30 a.m.Neles Corporation ("Neles") refers to the stock exchange release published by it on 29 September 2020 regarding Valmet Corporation's ("Valmet") proposal to Neles' Board of Directors to start discussions on a potential merger (the "Proposal"). The Board of Directors of Neles has carefully assessed the Proposal and, taking into account that the public tender offer by Alfa Laval AB (publ) (the "Tender Offer") is expected to expire on 22 October 2020, has urgently sought clarifying information on the Proposal. However, as the

The Covid-19 pandemic is expected to further affect RhoVac’s clinical phase IIb study

Lund, October 12, 2020. RhoVac AB (“RhoVac”) announces today that the company's clinical phase IIb study in prostate cancer, a multi-center study with the designation RhoVac-002 (“BRaVac”), is expected to be further delayed due to the prevailing Covid-19 pandemic. The recruitment rate in September now indicates full recruitment in Q2 2021. To reduce the effect of the delays caused by the pandemic, the number of clinics will be increased. The study is still expected to be carried out with existing funding.BRaVac is a randomized, placebo-controlled and double-blind study, with the primary

State Street and SimCorp Announce Intended Business Partnership, with Front-to-Back Investment Outsourcing Solution for EMEA Insurers

Strategic Business Partnership Demonstrates State Street and SimCorp’s Commitment to Insurance Clients in EMEA, with a Complete Front-to-Back Outsourcing Solution through the State StreetAlpha[SM]  Platform October 12, 2020 —State Street Corporation  (NYSE: STT) and investment management solutions and service provider, SimCorp  (OMXC25: SIM), today announced their intent to form a business partnership to provide a premier, fully integrated, front-to-back investment outsourcing solution for insurance firms in Europe, Middle

Leading Scandinavian IT Company selects Zalaris to deliver Multi-Country Payroll for their operations in Denmark, Sweden, and Norway

Zalaris ASA, a leading provider of SaaS-based Payroll and HR services, has signed a five-year agreement with one of the fastest growing IT companies in Scandinavia.As part of the agreement, Zalaris will implement outsourced Managed Payroll services for the company’s 1.200 employees in Denmark, Sweden, and Norway. The services will be powered by Zalaris’ proven Multi-Country Cloud solution for payroll, with an employee portal and mobile self-services for HR professionals, managers and employees. The solution will be integrated with the customer’s global HR solution to support one way of

Sivers IMA wins SEK4m order for new project with existing Fortune 100 customer

KISTA, Sweden, 12[th] October, 2020 - Sivers IMA Holding AB (Nasdaq First North Growth Market: SIVE) today announced that its subsidiary, CST Global, has received an order worth approximately SEK4m for a new project from one of its established, Fortune 100 customers.The order covers design, development and supply of semiconductor laser prototype devices for use in advanced, optical sensing applications. The order comes in addition to existing framework orders from the same customer and will be completed and billed during 2020. Thus, this Fortune 100 customer has now placed orders at Sivers

Nyfosa has acquired a property at a total value of approximately MSEK 65

Nyfosa has acquired an office property in Örnsköldsvik at a value of approximately MSEK 65, which complements Nyfosa's existing portfolio in the area with strong cash flows.The acquired property Köpmannen 1 in Örnsköldsvik comprises an area of approximately 7 thousand square meters consisting of mainly offices with a rental value of approximately MSEK 8. The tenants include Örnsköldsvik Municipality, Medborgarskolan, ABB, Nordic Wellness and Euro Accident. The average contract period is 2.0 years with an occupancy rate of 86 percent. Closing date for the property was October 5, 2020.

Elkem receives Enova financial support for planning the battery materials industrial plant

Elkem has received NOK 10 million in financial support from Enova to fund the initial planning of the potential large-scale battery materials plant in Norway, named Northern Recharge. The project aims to supply the fast-growing battery industry through a competitive production process and make batteries greener with lower CO2 emissions.“A positive investment decision requires competitive public support mechanisms and supportive government policies. Elkem is also inviting industrial and financial partners to participate. Securing this initial support from Enova is an important step as we

With the priority review underway at FDA, Oncopeptides moves forward with intent to file for conditional approval of melflufen with EMA

STOCKHOLM — October 12, 2020 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO) today announces that the Company has informed the European Medicines Agency, EMA, about its intention to submit an application for a conditional marketing authorization of melflufen (INN melphalan flufenamide) in the EU, based on the pivotal phase 2 HORIZON study in relapsed refractory multiple myeloma (RRMM).The decision to submit an application for conditional approval has been grounded on an in-depth analysis of the regulatory environment and is endorsed by key opinion leaders in the EU. Previously the Company

Issue of Equity

12 October 2020  Independent Oil and Gas plc Issue of New Shares and PDMR Shareholding  Independent Oil and Gas plc ("IOG" or "the Company"), (AIM: IOG.L), the development and production company focused on becoming a substantial UK gas producer, has today issued a total of 126,497 ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares"). On 9 October 2020, a notice was submitted by James Chance, a PDMR of the Company, to exercise 126,497 options over Ordinary Shares pursuant to a Salary Sacrifice Share Option agreement dated 6 October 2020 (the "Exercise"

COVID-19 antibodies advance and get US funding

9 October 2020 21:30 BST COVID-19 Long-Acting AntiBody (LAAB) combination AZD7442rapidly advances into Phase III clinical trials Two trials of AZD7442 will enrol over 6,000 adults for the prevention of COVID-19 withadditional trials enrolling ~4,000 adults for the treatment of SARS-CoV-2 infections US Government to invest ~$486m for development and supply of up to 100,000 doses and can acquire another one million doses AstraZeneca's long-acting antibody (LAAB) combination, AZD7442, will advance into two Phase III clinical trials in more than 6,000 participants at sites in

English version of PR published 20201012 at 07.33AM     SynAct Pharma completes part 1 of clinical phase II study with AP1189 in Rheumatoid Arthritis

SynAct Pharma AB ("SynAct") today announced that dosing of the leading candidate drug AP1189 was successfully completed in the second cohort (100 mg dose level) in part 1 of the company’s Phase IIa study in patients with Rheumatoid Arthritis (RA) with high disease activity.A data review on blinded non-validated data from 15 patients in the cohort of 100 mg dosing suggests that the compound is safe and well tolerated and shows that two thirds of the patients (10/15 patients) had a reduction in disease activity from severe to moderate or low disease activity during the 4 weeks treatment

SimCorp EMEA Signs non-binding Term Sheet with State Street Bank International GmbH

Company Announcement no. 38/2020 SimCorp EMEA and its current client State Street Bank International GmbH have today signed a non-binding Term Sheet setting out the main terms for entering into a strategic business partnership between the parties. The intention being to form a business partnership to provide a premier, fully integrated, front-to-back investment outsourcing solution for insurance firms in Europe, Middle East and Africa (EMEA). If and when the Term Sheet translates into a final strategic agreement, such agreement will become a "large contract" and SimCorp will disclose

Tokmanni’s financial information and Annual General Meeting in 2021

Tokmanni Group Corporation     Stock exchange release     12 October 2020 at 8:30 a.m.Tokmanni Group Corporation will publish its Financial Statement Release, Half Year Financial Report and two Business Reviews during 2021 as follows: 12 February 2021: Financial Statements Review for 202029 April 2021: Business Review for January-March 202129 July 2021: Half Year Financial Review for January-June 202129 October 2021: Business Review for January-September 2021 The 2020 Report by the Board of Directors and Financial Statements will be published during week 8. Tokmanni's Annual

Nomination Committee appointed for the Annual General Meeting 2021

The Nomination Committee ahead of the 2021 consists of: · Erik Malmberg, Actor SCA, Chair of the Nomination Committee · Carl Gustafsson, Didner & Gerge Fonder AB · Suzanne Sandler, Handelsbanken Fonder AB · Lena Hofsberger, Chair of Ambea AB (publ). Shareholders who wish to submit proposals to the Nomination Committee can do so on the following e-mail address: valberedning@ambea.se or to below address: Ambea ABValberedningenc/o Jacob Persson Box 1565SE-171 29 Solna, Sweden The Nomination Committee’s proposals shall be presented in the convening notice made

Targovax granted European Patent for ONCOS-102 in combination with checkpoint inhibitors

Oslo, 12 October 2020: Targovax ASA (“Targovax” or “the Company”; OSE: TRVX), a clinical stage immuno-oncology company developing oncolytic viruses to target hard-to-treat solid tumors, today announce that the European Patent Office has granted European Patent no 3293201. The patent covers the use of ONCOS-102 in combination with checkpoint inhibitors.Torbjørn Furuseth, Chief Financial Officer of Targovax, said: "We are delighted that this European patent has been granted, further strengthening Targovax's intellectual property portfolio covering the very important combination of ONCOS-102

Leading Scandinavian accounting firm with strategic partnership with 24SevenOffice

ECIT AS, which is one of the largest accounting firms in Scandinavia with 1,400 employees and close to 1,6 billion SEK in revenue, establishes a strategic business unit specialized on 24SevenOffice technology including AI accounting, and best practice. ECIT will through that business unit acquire new accounting firms mainly in Norway and Sweden where all portfolio companies will use the 24SevenOffice accounting/ERP system.ECIT has made a strategic choice to only focus on the AI (Artificial Intelligence) powered 24SevenOffice accounting/ERP system in all the acquired accounting firms. ECIT

First day of trading in warrants of series TO1 and TO2 has been set for October 14, 2020

As previously announced, Cereno Scientific AB (”Cereno” or the ”Company”) has carried out a directed issue of shares and warrants of series TO1 and TO2 with issue funds of approximately SEK 60 million (the “Directed Issue”). In addition to the Directed Issue, the Company has simultaneously issued warrants of series TO1 and TO2 granted to (i) the Companys’s existing shareholders as compensation for the dilution caused by the Directed Issue and to (ii) Formue Nord Fokus A/S in its capacity as lender. The Company hereby announces that the first day for trading for the warrants of series TO1 and

UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 09.10.2020

United Bankers Corporation NOTIFICATION 09.10.2020 at 18:30 UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 09.10.2020 Date 09.10.2020Exchange transaction BuyShare class UNIAVAmount 485Average price/share 9.0000 EURHighest price/share 9.0000 EURLowest price/share 9.0000 EURTotal price 4,365.00 EUR The shares held by United Bankers Corporation on 09.10.2020: UNIAV 20,802   On behalf of United Bankers Corporation  Skandinaviska Enskilda Banken AB (Publ) Antti

Aspire Global has Finalized the Acquisition of the Leading B2B Sportsbook Provider BtoBet

Aspire Global  has finalized the acquisition of 100% of the shares of BtoBet Ltd, a leading B2B sportsbook and technology provider. The acquisition of BtoBet, together with the acquisition last year of the leading aggregator and games studio Pariplay, has positioned Aspire Global among the world’s leading iGaming suppliers.The acquisition of BtoBet was announced on 17 September 2020 and following approval by North Macedonian authorities the transaction has been closed according to the initial conditions. BtoBet is consolidated as of 1 October 2020 by Aspire Global.

Extraordinary General Meeting of Sivers IMA has decided that the company's new name shall be Sivers Semiconductors

KISTA, Sweden, October 9[th], 2020 - Sivers IMA Holding AB (Nasdaq First North Growth Market: SIVE) publishes the statement from the Extraordinary General Meeting held today at the company's office in Kista.At the Extraordinary General Meeting, it was unanimously decided to change the company name of Sivers IMA to Sivers Semiconductors AB. Further, the Board can inform that Sivers IMA AB will be renamed Sivers Wireless AB and that Compound Semiconductor Technologies Global Ltd. will be renamed Sivers Photonics Ltd. For more information please contact:  Anders Storm, CEOTel: +46

SSM summons to a meeting with bondholders through a procedure in writing

At the request of SSM Holding AB (“SSM”), the agent has today summoned a meeting with the company’s bondholders by way of a procedure in writing to resolve on amending the terms and conditions of SSM’s outstanding bonds. The purpose of the amendment is to enable SSM to list the bonds with Nasdaq First North.At the request of SSM, the agent has today summoned a meeting with the company’s bondholders (the “Holders”) through a procedure in writing (the “Written Procedure”) to resolve on amending the terms and conditions of SSM’s outstanding bonds of a maximum of MSEK 700.0 (of which MSEK 300.0

#20-363 Changes to certain instruments on NGM

As from October 12, 2020, certain instruments are subject to changes.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

There are no items matching the current filter
There are no more items matching the current filter
Back to top